A novel 6-metabolite signature for prediction of clinical outcomes in type 2 diabetic patients undergoing percutaneous coronary intervention

Overview of attention for article published in Cardiovascular Diabetology, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,059 followers.

RT @Metabbot: A novel 6-metabolite signature for prediction of clinical outcomes in type 2 diabetic patients undergoing percutaneous corona…

06 Jul 2022

Reply Repost Favourite

A novel 6-metabolite signature for prediction of clinical outcomes in type 2 diabetic patients undergoing percutaneous coronary intervention. Cardiovasc Diabetol #metabolomics https://t.co/lDHWD3OCFK

06 Jul 2022

Reply Repost Favourite

A novel 6-metabolite signature for prediction of clinical outcomes in type 2 diabetic patients undergoing percutaneous coronary intervention https://t.co/7AXCggYSW9

06 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.